.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Transpara Breast AI is the technology of choice for first large-scale RCT in the United States to evaluate the role of AI in breast cancer screening.
.png)
ScreenPoint Medical expands in Spain with SACYL - EUSOBI 2025
ScreenPoint Medical partners with SACYL to bring AI for breast cancer detection to Castilla y León, enhancing screening accuracy and efficiency in Spain.
.png)
As imaging volume increases, breast radiology workflow must adapt
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
.png)
Breast imaging is awash in data – Artificial Intelligence can help
Breast imaging has unique stressors compared to other areas of radiology that can contribute to radiologist fatigue and error: what can be done?
.png)
Ikonopedia Enhances Breast Cancer Detection with Integrated AI Technology from ScreenPoint Medical
New Transpara integration provides radiologists with automated insights for more accurate and productive patient diagnoses and care.
.png)
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.